Analyst Rating: Will Lantern Pharma Inc (LTRN) Stock Beat the Market?

InvestorsObserver is giving Lantern Pharma Inc (LTRN) an Analyst Rating Rank of 5, meaning LTRN is ranked higher by analysts than 5% of stocks. The average price target for LTRN is $26 and analyst’s rate the stock as a Hold.

Wall Street analysts are rating LTRN a Hold today. Find out what this means to you and get the rest of the rankings on LTRN!

See Full LTRN Report

Why are Analyst Ratings Important?

You can learn a lot about a company from looking at it’s financial statements and comparing them to other companies. Analysts who cover an industry in depth can add even more to your research though. They typically follow a particular sector or industry very closely. They also pay attention to and ask questions on earnings conference calls and other events where they might learn information that does show up in the numbers. InvestorsObserver takes the average rating from these analysts, and then percentile ranks those averages. This lets you compare stocks in a much more granular way than just seeing the typical five-tiered rating system used on most of Wall Street.

What's Happening With Lantern Pharma Inc Stock Today?

Lantern Pharma Inc (LTRN) stock is higher by 8.45% while the S&P 500 is down -0.2% as of 9:56 AM on Monday, Mar 25. LTRN is up $0.90 from the previous closing price of $10.65 on volume of 93,814 shares. Over the past year the S&P 500 is up 31.33% while LTRN is up 152.18%. LTRN lost -$1.47 per share the over the last 12 months. Click Here to get the full Stock Report for Lantern Pharma Inc stock.